< Back to latest news & events


Oral Proceedings by videoconference (VICO) in oppositions proceedings to become permanent

November 2022

The pilot project for oral proceedings in opposition proceedings by video conference (VICO) started during the pandemic and has received positive feedback.[1]

The President of the EPO has therefore declared (Decision of 22 November 2022) that, as of 1 January 2023, VICOs will become the default format for oral proceedings in opposition. Only in exceptional circumstances when the opposition division permits it, will oral proceedings in opposition be conducted in person.

The president believes that VICO has enabled parties to save on time and money whilst reducing carbon emissions from travelling in person.

Accordingly oral proceedings will only be held in person if requested by a party or at the instigation of the Opposition Division if there are serious reasons against holding the proceedings by video conference. If a party’s request is refused the refusal is not separately appealable.

Given the experience during the pandemic, and as set out in the Pilot Project Final Report [1], the taking of evidence, including hearing witnesses and inspection, has been successfully conducted by VICO and so is not likely to amount to serious reasons for conducting oral proceedings in person. An exception may be where inspection cannot be adequately conducted using video equipment.

Please see here for the official notice from the EPO.

The decision of the President does not affect Oral Proceedings at the Boards of Appeal. Indeed, in the Enlarged Board of Appeal Decision G1/21 the Enlarged Board clearly stated that whilst oral proceedings by VICO were compatible with the right to be heard enshrined in the EPC they were suboptimal compared with in-person hearings and, as such, in-person hearings should, in the absence of a pandemic, be the default option (Reason 45).

Accordingly we do not expect the President’s Decision to have a knock-on effect at the Board of Appeal.

For further information please contact Dr Chris Moore, Head of Oppositions & Appeals.

[1] Pilot Project Final Report November 2022 (here) – over 77% of respondents found oral proceedings to be “good” or “very good”

Latest updates

Exam Success!

HGF are delighted to announce success for many of our colleagues in the recent exams on becoming qualified attorneys and would like to congratulate them on this fantastic achievement. Martyn …

Read article

In2ScienceUK continues to promote diversity and inclusion in STEM and IP with its award winning programme

HGF are proud sponsors of In2ScienceUK, a charity that gives young people from low-income backgrounds the opportunity to gain essential insights into science, technology, engineering, and mathematics (STEM) careers with …

Read article

Spotting innovation in digital health – and can you patent it?

Intellectual Property (IP) can add significant value to your business, providing a competitive edge over the market, as well as demonstrating sound business planning to help secure investment. There are …

Read article

Innovation at the heart of UK medtech strategy

The UK Department of Health and Social Care has recently published the government’s first ever medical technology strategy in an effort to accelerate access to innovative technologies. The strategy document …

Read article

How medtech start-ups can supercharge their IP for fundraising

Why is IP important for fundraising? Intellectual property (IP) rights underpin the value of most medtech start-up companies. IP rights include patents, design rights, trade marks, copyright and trade secrets …

Read article

What is EUDAMED and how will it affect your IP strategy?

The “European database on medical devices”, or “EUDAMED”, is the EU’s IT system created by the new Medical Devices Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR). When …

Read article